Found: 37
Select item for more details and to access through your institution.
Liposomally targeted cytotoxic drugs for the treatment of cancer.
- Published in:
- Journal of Pharmacy & Pharmacology, 2002, v. 54, n. 12, p. 1573, doi. 10.1211/0022357002243
- By:
- Publication type:
- Article
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 793, doi. 10.3390/ph16060793
- By:
- Publication type:
- Article
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1191, doi. 10.3390/vaccines12101191
- By:
- Publication type:
- Article
Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 2, p. 267, doi. 10.1002/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D
- By:
- Publication type:
- Article
Biodistribution and Pharmacokinetics of <sup>111</sup>In-DTPA-Labelled Pegylated Liposomes after Intraperitoneal Injection.
- Published in:
- Acta Oncologica, 2003, v. 42, n. 2, p. 147, doi. 10.1080/02841860310005697
- By:
- Publication type:
- Article
Les tumeurs dormantes prises au piège de la récidive.
- Published in:
- Médecine Sciences, 2014, v. 30, n. 4, p. 355, doi. 10.1051/medsci/20143004006
- By:
- Publication type:
- Article
A simple method to cure established tumors by inflammatory killing of normal cells.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 9, p. 1125, doi. 10.1038/nbt1007
- By:
- Publication type:
- Article
A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 7, p. 771, doi. 10.1038/nbt835
- By:
- Publication type:
- Article
Vironcology?not yet, but soon?
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 11, p. 1020, doi. 10.1038/nbt1101-1020
- By:
- Publication type:
- Article
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy.
- Published in:
- Nature Medicine, 2008, v. 14, n. 1, p. 37, doi. 10.1038/nm1681
- By:
- Publication type:
- Article
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.
- Published in:
- Nature Medicine, 2005, v. 11, n. 10, p. 1073, doi. 10.1038/nm1297
- By:
- Publication type:
- Article
Accidental tourist guides.
- Published in:
- 1992
- By:
- Publication type:
- Bibliography
CLINICAL REVIEW 132: The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 7, p. 3327, doi. 10.1210/jcem.86.7.7641
- By:
- Publication type:
- Article
Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases.
- Published in:
- Neurosurgical Focus, 2022, v. 52, n. 2, p. 1, doi. 10.3171/2021.11.FOCUS21571
- By:
- Publication type:
- Article
Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma.
- Published in:
- Neurosurgical Focus, 2021, v. 50, n. 2, p. 1, doi. 10.3171/2020.12.FOCUS20855
- By:
- Publication type:
- Article
Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 14, p. 7714, doi. 10.3390/ijerph18147714
- By:
- Publication type:
- Article
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1106, doi. 10.3390/cancers13051106
- By:
- Publication type:
- Article
How To Train Your Oncolytic Virus: the Immunological Sequel.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 11, p. 1881, doi. 10.1038/mt.2014.188
- By:
- Publication type:
- Article
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 2, p. 348, doi. 10.1038/mt.2012.204
- By:
- Publication type:
- Article
Phase II Trial of Intravenous Administration of Reolysin<sup>®</sup> (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 10, p. 1998, doi. 10.1038/mt.2012.146
- By:
- Publication type:
- Article
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1757, doi. 10.1093/neuonc/noaa126
- By:
- Publication type:
- Article
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 425, p. 1, doi. 10.1126/scitranslmed.aar2041
- By:
- Publication type:
- Article
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
- Published in:
- Viruses (1999-4915), 2015, v. 7, n. 11, p. 5889, doi. 10.3390/v7112914
- By:
- Publication type:
- Article
Intratumoral immunotherapy: using the tumour against itself.
- Published in:
- Immunology, 2005, v. 114, n. 1, p. 11, doi. 10.1111/j.1365-2567.2004.02001.x
- By:
- Publication type:
- Article
Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac085
- By:
- Publication type:
- Article
Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90718-1
- By:
- Publication type:
- Article
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 4, p. 844, doi. 10.1002/ijc.26447
- By:
- Publication type:
- Article
Unbiased selection of bone marrow derived cells as carriers for cancer gene therapy.
- Published in:
- Journal of Gene Medicine, 2007, v. 9, n. 11, p. 927, doi. 10.1002/jgm.1089
- By:
- Publication type:
- Article
Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein.
- Published in:
- Journal of Gene Medicine, 2002, v. 4, n. 6, p. 592, doi. 10.1002/jgm.306
- By:
- Publication type:
- Article
Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 9, p. 1599, doi. 10.1038/mt.2010.120
- By:
- Publication type:
- Article
Immunology and Gene Therapy: Shoulder to Shoulder Into the Fray.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 12, p. 1910, doi. 10.1038/mt.2008.212
- By:
- Publication type:
- Article
Treg Depletion–enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 7, p. 1217, doi. 10.1038/mt.2008.83
- By:
- Publication type:
- Article
A System for Small-Molecule Control of Conditionally Replication-Competent Adenoviral Vectors
- Published in:
- Molecular Therapy, 2002, v. 5, n. 2, p. 195, doi. 10.1006/mthe.2002.0531
- By:
- Publication type:
- Article
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14568-7
- By:
- Publication type:
- Article
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 368, doi. 10.1186/1471-2407-12-368
- By:
- Publication type:
- Article